Pfizer Signs China Partnership to Make Paxlovid Covid Pills Locally
Chinese drugmaker Zhejiang Huahai Pharmaceutical Co. Ltd. has entered an agreement with Pfizer Inc. to manufacture the U.S. giant’s Covid-19 pill Paxlovid in China.
Shanghai-listed Huahai Pharmaceutical said Thursday that it has signed a non-exclusive production and supply agreement with the Chinese subsidiary of Pfizer. Under the agreement, Huahai Pharmaceutical will produce Paxlovid in China for five years.
- MOST POPULAR